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Abstract
Background Globally, health expenditure as a percentage
of GDP has increased in recent years, so evaluating the
health care systems used in different countries is an
important tool for identifying best practices and improving
inefficient health care systems.
Objective We investigate health system efficiency at the
country level based on OECD health data. We focus on
several aspects of health care systems to identify specific
inefficiencies within them. This information hints at
potential policy interventions that could improve specific
parts of a country’s health care system.
Methods A discussion is provided of ideal-typical evalu-
ations of health systems, ignoring data restrictions, which
provide the theoretical basis for an analysis performed
under factual data restrictions. This investigation includes
health care systems in 34 countries and is based on OECD
health data. Health care system efficiency scores are
obtained using data envelopment analysis (DEA). Relative
productivity measures are calculated based on average
DEA prices. Given the severe data limitations involved,
instead of performing an all-encompassing analysis of each
health care system, we focus on several aspects of each
system, performing five partial analyses.
Results For each country, the efficiencies yielded by the
five partial analyses varied considerably, resulting in an
ambiguous picture of the efficiencies of the various health
care systems considered. A synopsis providing compre-
hensive rankings of the analyzed countries is provided.
Conclusion Analysis of several aspects of the health care
systems considered here highlights potential improvements
in specific areas of these systems, thereby providing
information for policymakers on where to focus when
aiming to improve a country’s health care system.
Key Points for Decision Makers
The analysis reveals strong within-country
heterogeneity among the efficiencies of five different
aspects of the health care system.
The results for several aspects of health care systems
highlight potential improvements in specific areas of
these systems.
Benchmark countries with highly efficient health
care systems often present systems with high output
and mediocre input or with mediocre output and low
input, meaning that policymakers can select a role-
model system according to their preferences.
1 Introduction
Providing health care is an important service of any
country’s government, and the efficiency of the health care
system is a recurring and relevant key topic in health policy
discussions. According to the Global Health Expenditure
database of the World Health Organization (WHO), health
expenditure as a percentage of GDP has increased strongly
in recent years. Due to demographic changes, we can
assume that this trend will continue in the coming decades.
Hence, it is important to evaluate the efficiency of the
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health care systems of various countries. Efficiency anal-
ysis can point to potential input reductions or potential
output increases. Therefore, benchmarking health care
systems is important for identifying best practices and
inefficient health care systems.
The contribution to the existing literature provided by
the present paper is threefold. Firstly, we provide a theo-
retical discussion of ideal-typical measurements of health
care efficiency, which serves as a yardstick when dealing
with the severe data limitations that are often present when
performing empirical analysis in this field. Secondly,
because an all-encompassing analysis that includes inputs
and outputs of very different aspects of the health care
system can lead to compensating effects that hide specific
strengths and weaknesses of that system, we perform five
individual efficiency analyses, each focusing on different
aspects of health care systems, thus avoiding any com-
pensating effects. For example, Retzlaff-Roberts et al. [1]
have shown that countries may be efficient at one aspect of
health care (e.g., at improving life expectancy) but ineffi-
cient at other aspects (e.g., at reducing mortality). Thirdly,
in addition to DEA efficiency scores, we provide a measure
of relative productivity based on average prices, which
prevents both the strengths of some health care systems
from being exaggerated and unrealistic zero weights from
being applied to specific inputs or outputs.
We investigate health care system efficiency at the
country level based on OECD health data and apply data
envelopment analysis (DEA). As the results and the sci-
entific value of health care efficiency analysis depend
crucially on the appropriateness of the inputs and outputs
used, we discuss input and output choices in detail. In an
empirical efficiency analysis, we consider several aspects
of health care systems and conduct five partial analyses
focusing on medical inputs and surgery provision; medical
inputs and mortality prevention; lifestyle and life expec-
tancy from birth; income, health expenditure, and life
expectancy from birth; and relative expenditure, income
inequality, and life expectancy from birth. We use data
from 16–30 OECD countries in these five partial analyses.
For each country, we observed strong variations in
efficiency across the five analyses; some countries are
efficient at producing a particular health care output but
very inefficient at producing other outputs. This empha-
sizes the value of disaggregated analysis, as one all-en-
compassing analysis including many inputs and outputs
from different aspects of a health care system would mask
specific inefficiencies in that system.
Furthermore, we find that different countries have
achieved high efficiency in rather different ways; e.g., some
health care systems yield low output but are highly efficient
because only very low input quantities are invested in the first
place. In terms of policy recommendations, the benchmark
health care system will of course depend on the preferences
of the country that is choosing a health care system. These
detailed results enable countries to prioritize and to focus on
improving specific aspects of health production. As some
inputs cannot be changed in the short term (e.g., health-re-
lated behavior), focusing on output improvements may be a
more relevant approach for policymakers.
This paper is organized as follows: Sect. 2 contains some
general methodological considerations. Section 3 provides a
brief overview of the relevant literature on international com-
parisons of health care system efficiency. In Sect. 4, we discuss
measurement issues, input and output selection, the database,
and the methodology used. Section 5 contains the empirical
results from thefive separate analyses and a synopsis. Section 6
draws conclusions and contains policy implications.
2 General Methodological Considerations
Data envelopment analysis is a very popular method of
obtaining efficiency scores for decision-making units
(DMUs) in general and for countries’ health care systems
in our case. Its charm is its simplicity, as different health
care systems are compared to the most efficient health care
system, which most often is a synthetic health care system
obtained as a linear combination of the observed health
care systems of countries belonging to the reference set.
Furthermore, the method is nonparametric, meaning that
neither questionable assumptions about functional relations
between inputs and outputs nor distributional assumptions
need to be made.
2.1 Productivity, Relative Efficiency,
and the Weighting Scheme
The productivity of a health care system is the ratio of the




The aim of efficient production is to maximize the output
given a certain amount of input or to minimize the input
given a certain amount of output. In our empirical effi-
ciency analysis, we only consider the concept of relative
efficiency. That is we simply compare the actual input
amounts with lower hypothetical inputs of a (potentially
synthetic) efficient health system given the actual output
amounts. Hence, health care systems regarded as efficient
serve as a benchmark when calculating the relative effi-
ciency of the health care system being analyzed.
Note that a simple comparison of output relative to input
is only possible if we sum the multiple different inputs for a
health care system into a single input measure and the
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multiple different outputs of the system into a single output
measure. As the quantities of different goods cannot be
summed, weights must be used when aggregating them.
We denote the outputs by yr ðr ¼ 1; . . .; sÞ, the inputs by xi
ði ¼ 1; . . .;mÞ, the output prices by ur ðr ¼ 1; . . .; sÞ; and the
input prices by vi ði ¼ 1; . . .;mÞ. j is an index that specifies
the health care system considered; i.e., each value of ðj ¼
1; . . .; nÞ refers to a different health system. Given the input
prices vi and the output prices ur, we can compare the sum of








Note that scaling the output prices c  ur and the input
prices k  vi alters the productivities but not the resulting
relative efficiency measure, as the scaling factors cancel
out. Hence, the resulting efficiency measure depends only
on the relative input and output prices chosen.
2.2 Charnes–Cooper–Rhodes model
The ratio of weighted outputs to weighted inputs depends
on the weighting scheme chosen. So how can we judge the
efficiencies of DMUs if they depend on the weighting
scheme applied? The idea behind the Charnes–Cooper–
Rhodes model (CCR model) is to choose, for each DMU,
the set of input and output prices that yields the maximum
ratio of weighted output to weighted input, given a set of
restrictions:
1. All input and output prices must be non-negative.
2. For all DMUs, the weighted output must not exceed
the weighted input.
For the DMU under consideration (o), we choose v and u such
that its productivity h is maximized, under the constraint that,
for all n DMUs, the weighted output does not exceed the
weighted input and all prices are non-negative. Therefore, the
problem is expressed as a linear programming problemwhich
can be solved by means of the simplex algorithm. Obviously,
the number of restrictions that have to be met here is rather
large: it is the number of firms (n) plus the number of inputs
(m) plus the number of outputs (s).
This maximization problem must be solved for each of
the n DMUs, and nþ mþ s constraints have to be met in












 1 ðj ¼ 1; . . .; nÞ
vi 0 ði ¼ 1; . . .;mÞ
ur  0 ðr ¼ 1; . . .; sÞ:
ð3Þ
We only consider positive input prices v[ 0 and positive
input amounts x[ 0; and we normalize the input of DMU
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i xijvi ðj ¼ 1; . . .; nÞ
vi 0 ði ¼ 1; . . .;mÞ
ur  0 ðr ¼ 1; . . .; sÞ:
ð4Þ
h denotes the solution to the maximization problem. v
and u are vectors of the optimal input and output prices. A
DMU is efficient only if h ¼ 1. In this case, its weighted
output equals its weighted input and the restriction that the
weighted output must not exceed the weighted input is just
met. Aside from that restriction, we have the non-
negativity constraints v  0 and u  0. If h\1; then,








i . DMUs for which this equality holds
belong to the reference set E0o of the inefficient DMU o,
where













The set of efficient DMUs in E0o spans the ‘‘efficient
frontier’’ for inefficient DMU o. Hence, all inefficient
DMUs are measured relative to their specific reference sets.
3 Literature Review: International Comparisons
of Health System Efficiency
There is a body of literature in which the efficiencies of the
health care systems used in various countries are compared.
Most of these studies make use of OECD health data or
WHO health data. The World Health Report (WHR, e.g.,
[2]), published by the WHO, provides information on how
well 191 countries are performing in relation to several
health goals (improving health status and responsiveness,
equality of financing) given their resources, and publishes
health care system rankings. Efficiency is calculated as the
ratio of observed performance to maximum performance,
estimated by a fixed effects regression approach with
observed inputs and outputs (see [3]; for more details, see,
e.g., [4]). Evans et al. [3] evaluated the performance of 191
WHO member states using healthy life expectancy as
outcome and health expenditure per capita and average
years of schooling as input measures. They found effi-
ciency to be positively related to health expenditure. Well-
performing countries included Oman, Malta, Italy, France,
and San Marino. The worst-performing countries were
Zimbabwe, Zambia, Namibia, Botswana, and Malawi.
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They concluded that countries with a good health level did
not necessarily have an efficient health care system.
The WHO technique has been criticized for several
reasons. Gravelle et al. [4] address the measure of effi-
ciency, the fixed effects approach, the use of logarithms,
and the omission of income from the WHO analyses. They
observed substantial sensitivity of the results to the model’s
specifications, with the country’s efficiency score and rank
varying considerably depending on the specifications
applied. In particular, they criticize the use of within-
country variation, because most of the variation occurs
between countries.
Hollingsworth and Wildman [5] compare parametric
and nonparametric techniques [time-varying fixed effects,
DEA, Malmquist indices, stochastic frontier analysis
(SFA)] and emphasize that league tables hide valuable
information on efficiency changes. In addition, they rec-
ommend that, because of their very different characteris-
tics, OECD and non-OECD countries should be analyzed
separately, and that further stratification by GDP or geo-
graphical region would also be useful.
Based on the critique of Gravelle et al. [4] concerning
the between-country variation, Greene [6] used additional
country-specific variables to account for some of the
heterogeneity. Aside from health care expenditure and
educational level, information on the income distribution
(GDP and Gini coefficient), government effectiveness,
dummy variables for tropical location and for OECD
membership, population density, and an indicator relating
to the allocation of health care expenditure between the
private and public sector were included. The income level
and the income inequality appeared to have sizeable
impacts on the efficiency. Accounting for heterogeneity
changed the rankings of the countries considerably.
As we use OECD data for our analysis, studies based on
these data are reviewed here in more detail. Retzlaff-Roberts
et al. [1] estimate the technical efficiency in the use of health
care resources for 27 countries by applying input- and out-
put-oriented DEA allowing for variable returns to scale
(VRS). Based on the OECD health data for the year 2000,
infant mortality and life expectancy at birth are defined as
outputs. Inputs are categorized into two groups; one repre-
senting the social environment of the country (school
expectancy, Gini coefficient, tobacco use) and the other
consisting of health-related inputs [practicing physicians,
inpatient beds, magnetic resonance imagers (MRIs), share of
GDP allocated to health care]. They find 13 countries to be
efficient according to both outputs: Australia, Canada,
France, Greece, Ireland, Japan, Korea, Mexico, Norway,
Spain, Sweden, Turkey, and the UK. This group includes
countries with good health outcomes as well as those with
poor health outcomes. Six countries are efficient at pro-
ducing low infant mortality only, but not at producing high
life expectancy. Eight countries are inefficient with respect
to both outputs: Austria, Belgium, Germany, Hungary,
Netherlands, New Zealand, Switzerland, and the USA (i.e.,
again including countries with good and poor health out-
comes). The authors conclude that a country can be tech-
nically efficient/inefficient at any level of health outcome.
On average, inefficient countries could reduce infant mor-
tality (with constant inputs) by 14.5% and increase life
expectancy by only 2.1%. According to the input-oriented
model, OECD countries can on average reduce inputs by
14.0 and 21.0%, respectively, without changing infant
mortality and life expectancy.
Bhat [7] compares 24 OECD countries and uses the
number of practicing physicians, nurses, inpatient beds, and
pharmaceutical consumption as inputs. Output is defined
based on three proportions of the population: those aged
0–19 years, those aged 20–64 years, and those aged 65 years
or older, as health expenditure varies strongly with the age
structure of the population. A DEA with constant returns to
scale (CRS) identifies eight countries as efficient: Denmark,
Japan, Netherlands, Norway, Portugal, Sweden, Turkey, and
the UK. The lowest efficiencies are found for Belgium,
Iceland, and Australia. Institutional arrangements seem to
have an impact on efficiency, as public-contract and public-
integrated countries are more efficient than countries with a
public-reimbursement system. Here, public-reimbursement
systems involve the retrospective indirect payment of pro-
viders for services. In the public-contract model, providers
are paid a fee directly for their services, while the public-
integrated model involves direct payment through global
budgets and salaries. Control of spending is highest for the
public-integrated model and lowest for public-reimburse-
ment systems.
Afonso and Aubyn [8] analyze 24 OECD countries by
applying two nonparametric approaches: free disposable
hull (FDH) and DEA (input- and output-oriented, CRS and
VRS). Just as in the study by Bhat [7], the numbers of
doctors, nurses, and in-patient beds serve as inputs, and, in
accordance with Retzlaff-Roberts et al. [1], infant survival
rate and life expectancy are the health outcomes. Eight
countries are found to be efficient when using the FDH and
the DEA approaches: Canada, Japan, Korea, Portugal,
Spain, Sweden, the UK, and the USA.
In a second paper, using a semiparametric two-stage
approach, Afonso and Aubyn [9] find a strong relationship
between health system inefficiencies and nondiscretionary
inputs. An output-oriented DEA (VRS) based on principal
components of base inputs (practicing nurses, physicians,
beds, MRI) and outputs (infant survival rate, life expectancy,
potential years of life not lost) identifies seven countries as
efficient: Canada, Finland, Japan, Korea, Spain, Sweden, and
the USA. On average, countries can increase their output by
40%. In a second stage, the fact that inefficiencies are not
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necessarily caused by factors under the purview of the health
care system is focused upon. The influence of nondiscre-
tionary inputs on the efficiency is evaluated based on a Tobit
regression. Here, the nondiscretionary inputs of GDP per
capita, educational level, obesity, and tobacco consumption
appear to have an impact on a country’s efficiency. Correcting
for environmental influences alters efficiency scores and
country rankings. Countries that were poorly ranked before
come closer to the efficient frontier (e.g., Denmark, Czech
Republic, Hungary, Slovak Republic, and the UK), whereas
the rankings of other countries decline (Canada, Sweden,
USA, Japan).
A within-country comparison over time rather than a
between-country comparison is conducted by Adang and
Borm [10]. They apply an output-oriented DEA (CRS) and
a Malmquist index over the period 1995–2002 and calcu-
late Spearman correlation coefficients to identify the rela-
tionship between changes in productivity and changes in
satisfaction in health care. Inputs are the share of GDP
allocated to health care, the number of practicing physi-
cians, and tobacco use. Outputs are life expectancy at birth
and infant mortality. No association between the economic
performance of the health care system and the change in
satisfaction with the health care system is found.
A critical study involving between-country comparisons of
health production efficiency is provided by Spinks and Hol-
lingsworth [11]. Twenty-eight countries are analyzed based
on OECD health data between 1995 and 2000. School
expectancy years, unemployment rate, GDP per capita, and
health expenditure per capita serve as inputs; life expectancy
at birth serves as the health output indicator.An input-oriented
DEA (VRS) analysis and Malmquist indices reveal that six
countries were efficient in 1995 (Turkey, Mexico, Korea,
Greece, Spain, and Japan) and eight countrieswere efficient in
2000 (Turkey, Mexico, Korea, Greece, Spain, Japan, Iceland,
and Switzerland). Most of these efficient countries are lower
ranked in GDP per capita and health expenditure per capita.
Table 1 provides an overview of the input and output
measures used in previous research based on OECD data.
An overview of the literature that has utilized the OECD
data is given in Table 8 in the Appendix.
A recent study by Hsu [12] uses world development
indicators and global development finance data for 46
countries between 2005 and 2007 to compare the efficiency
of government health expenditure between Europe and
Central Asia. Health expenditure per capita is used as input
for aDEA. In addition, the effects of environmental variables
such as the population density, GDP per capita, hospital
beds, average years of primary schooling, and a regional
effect (Central Asia versus Europe). Outputs are life
expectancy at birth, infant mortality rate (reciprocal), and
measles immunization. Their results indicate that health
spending in Europe is less efficient than that in Central Asia.
Moreover, the number of hospital beds and education posi-
tively affect efficiency. Using the same data and a super
slack-based measure (SBM), Hsu [13] further discriminates
between efficient countries in order to rank them separately.
Medeiros and Schwierz [14] apply models with different
combinations of inputs and outputs to assess the robustness
of the results, and they conclude that efficiency scores vary
strongly across efficiency models.
Summing up, we observe that a variety of input and output
measures have been used in previous studies focusing on
different sets of countries. However, the process by which
the inputs affect the outputs is often insufficiently identified.
As many studies do not include an ideal-typical characteri-
zation of the effect of health care provision on population
health, the procedure used to select inputs and outputs often
lacks the required theoretical underpinning. Based on this
literature review, we considered it necessary to first try to
characterize an ideal-typical measurement of the effects of a
health system on population health, which would then serve
as the foundation for operationalization under the restrictions
of the OECD database.
The contribution of the present work to the existing lit-
erature is threefold. Firstly, it provides a theoretical discus-
sion of ideal and operationalized inputs and outputs, which
are important when dealing with severe data limitations.
Secondly, it extends previous research by applying separate
models and therefore emphasizing different objectives of the
health care system. Thirdly, along with DEA efficiency
Table 1 Inputs and outputs used in the OECD data
Inputs Outputs
Health expenditure per capita Life expectancy (at birth)
Percentage of health care
expenditure
Infant mortality (survival) rate
Practicing physicians Population aged 0-19 years;
population aged 20-64 years;
population aged
65 years and older












MRI magnetic resonance imaging, GDP gross domestic product
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scores, it provides an efficiency measure based on average
prices, which prevents the strengths of particular health care
systems from being overemphasized and specific poorly
performing inputs or outputs from being overlooked.
4 Methods
The results and the scientific value of health care efficiency
analysis depend crucially on the appropriateness of the
inputs and outputs considered in the analysis. We start our
discussion by formulating ideal-typical concepts (as
defined by Max Weber) of inputs and outputs. These ideal-
typical concepts are then contrasted with the available
inputs and outputs in the OECD database.
4.1 Ideal-Typical Input Measures
Ideally, the inputs should reflect all of the resources used
by the health care system to improve the health status of
the population. The inputs can be broadly classified into
labor (in its different forms), materials, and the services
provided by the capital stock in use. In classical eco-
nomics,the total input is considered the sum of the direct
labor input, the indirect labor input associated with the
material consumed during the process of producing health
care, and the indirect labor input associated with the por-
tion of the capital stock that is consumed during the pro-
duction process. In contrast to the classical use of labor
coefficients to transform the quantities of all the different
inputs into amounts of labor, other weighting schemes can
be applied when aggregating the inputs.
The direct labor inputs can be broadly categorized into
service by doctors, service by therapists (non-doctoral),
services by nurses and care workers, services by pharma-
cists, and services by administrative staff. The material
inputs can be further categorized according to commodity
group into chemical goods, care materials, etc. The fraction
of the capital stock consumed may be disaggregated into
buildings, machinery (e.g., for drug production), and
equipment (e.g., beds, MRIs, etc.; see Fig. 1).
Readers familiar with input–output tables could con-
ceptualize the health system as one specific sector, which
would provide the necessary information as quantities with
different units of measurement. For instance, this infor-
mation could be expressed in labor values, based on
employment data for the relevant sectors (ignoring the
issue of nonhomogeneous labor for the moment).
4.2 Ideal-Typical Output Measures
Starting with the idea of describing the health sector as an
individual sector in the input–output analysis, the output
would be the aggregated value of health goods and services
produced, thereby reflecting the individual valuation of the
output from the buyers’ (patients’) perspective. But, as
most of the products of the health system are not ‘‘sold’’ at
market prices, this concept of subjective valuation of the
output is not feasible.
Going back to an ideal-typical concept of health output,
three quantities may best capture the output of the health
sector: the amount of pain relief, the number of additional
(quality-adjusted) life years, and the increase in well-being
(e.g., achieved through the use of prostheses) caused by
treatment within the health system. These initially purely
theoretical concepts could perhaps be evaluated by sum-
ming the values of each measure in the various subsectors:
hospitals, medical practices, pharmacies, etc. Alternatively,
the aggregation could be performed by summing across
patient categories (e.g., acute patients, patients with
chronic conditions, etc.) or population subgroups (e.g.,
grouped by age and sex). Hence, ideal-typical outputs
could be the number of extra pain-free hours (weighted by
objective pain measures) due to treatment, the sum of the
extra (quality-adjusted) life years (QALYs) gained by
undergoing treatment within the health system, and the
increase in well-being caused by treatment (see Fig. 2).
Obviously, the causal relation between treatments and
measures often cannot be verified in practice. Furthermore,
the intersubjective comparable measures of pain relief that
need to be aggregated are purely theoretical, as is the
calculation of additional (quality-adjusted) life years or the
increase in well-being. Nevertheless, we consider this
ideal-typical reasoning to be very important when judging
the adequacy of available output indicators.
4.3 The OECD Database
The OECD collects health-related data on OECD countries













Fig. 1 Ideal-typical inputs. MRI magnetic resonance imaging
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The World Bank, the Global Health Observatory data
repository of the World Health Organization (WHO), and
other OECD databases (OECD.Stat). These data are com-
plemented by national databases (e.g., statistical offices,
federal ministries).
The OECD health data provide information on health
status (e.g., mortality, morbidity), nonmedical determinants
of health (e.g., tobacco, alcohol, food consumption, obe-
sity), health care resources (e.g., health employment and
education, physical and technical resources), health care
utilization (e.g., consultations, immunization, screening,
hospital stay, surgical procedures, waiting times), health
care quality indicators, the pharmaceutical market, expen-
diture on health, social protection, demographic factors
(e.g., population, fertility, labor force), and economic fac-
tors (e.g., GDP, wages) (see [15] for example).
Differences in the data sources, definitions, and
methodologies used for variable construction affect com-
parability across countries. For instance, when comparing
the number of practicing physicians, some countries
include doctors working in administration, management,
academic, and research positions, while others only include
doctors who provide care directly to patients. Similarly,
when comparing the number of nurses, some countries also
include midwives (considered to be specialist nurses) in
their figures, while others do not. When comparing surg-
eries, it is important to realize that classification and reg-
istration practices differ among countries. For example,
some countries group data on total hip replacements and
partial replacements together, while others only provide
total hip replacement data. Countries also apply different
rules for registering technical equipment (e.g., MRI units or
CT scanners): most OECD member states include all such
equipment, regardless of whether it is used in a hospital,
but some countries only include equipment used in hospi-
tals (see [16]).
Moreover, a lack of standardization in health interview
surveys (differences in wording and in response categories)
complicates between-country comparisons. For example,
the perceived health status can be retrieved from The
European Union Survey on Income and Living Conditions
(EU-SILC), but in this case there is no measurement
standardization across OECD countries. Similarly,
countries may differ in the data they provide on health-
related behavior such as tobacco and alcohol consumption
(see [16]).
The main source of data on infant mortality in most
European countries is the Eurostat database. Some of the
between-country variation in infant mortality rates is
probably due to differences in registering practices for
premature infants. The methodology used to estimate life
expectancy, data on which are again mainly retrieved from
the Eurostat database, may also differ between countries.
Life expectancy at birth for the whole population is cal-
culated by the OECD Secretariat (see [16]).
These limitations in between-country comparability
should be kept in mind when interpreting the empirical
results. Moreover, we face the problem of missing data in
the OECD database, which limits empirical analyses dra-
matically. For our analysis, we used the OECD health data
for 2012. In the rather rare cases in which entries were
missing for 2012 but available for 2011, we used the 2011
values to substitute for the missing 2012 values. Only six
countries could be included in all five of the partial anal-
yses, so the number of available scores for partial analyses
varied between 1 and 5 for the 34 countries.
4.4 Available Input and Output Measures and their
Adequacy
We scanned the complete available OECD health database
to find the most adequate input and output indicators. Not
unexpectedly, the available indicators do not remotely
coincide with the ideal-typical measures discussed above.
Note that we disregarded from the start all indicators with
\20 valid data (i.e., with values from\20 countries).
4.4.1 Inputs
In the literature, health care expenditure is often used as an
input measure. Unfortunately, however, some of this
expenditure depends on the country’s wage levels (for nur-
ses, physicians, etc.)while the rest does not (e.g., expenditure
on imported magnetic resonance imaging machines).
Moreover, disentangling the effects of private and public
spending on health outcomes is a challenging task (see [17]),
and it is unclear how variations in the public financing of
health care influence a country’s health outcomes (see [6]).
Not all of the public expenditure on health has a measurable
effect on health outcomes (e.g., the effect of the expenditure
on tooth cleaning). Furthermore, we face the problem of
differentiating between health expenditure and consumption
(e.g., designer and basic spectacles).
Nonfinancial health care resources often used in the
literature include practicing physicians and nurses and
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Fig. 2 Ideal-typical outputs
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account health care technology, technical equipment such
as MRI units is considered medical input (see [1]). Medical
services such as surgeries and transplantations are not
usually considered in research, but are assumed to be
highly relevant to health care efficiency.
Due to issues with availability and missing data, we
cannot cover all of the aspects of the ideal-typical inputs
mentioned above. We categorize the inputs used into the
three broad categories of basic medical inputs, intermediate
medical inputs (accomplishments, provided services), and
financial inputs:
1. Basic medical inputs
– hosp_beds: total hospital beds per 1000 population
– physicians: practicing physicians per 1000
population
– nurses: practicing nurses per 1000 population.
2. Intermediate medical inputs (used as outputs)
– cataract: cataract surgery, total number of proce-
dures per 100,000 population
– bypass: coronary artery bypass graft, inpatient
cases per 100,000 population
– kidney: transplantation of kidney, total number of
procedures per 100,000 population.
3. Financial inputs
– healthgdp: health expenditure as a share of gross
domestic product
– healthspend: total health expenditure per capita in
USA dollars based on PPP.
4.4.2 Outputs
Unfortunately, the ideal (or almost ideal)-typical output
measures that have already been mentioned are not avail-
able in health data sets. Life expectancy and infant mor-
tality are often used as health output indicators, but these
outputs are, of course, incomplete measures of health status
since they do not reflect the quality of life of the living.
Life expectancy depends strongly on social, cultural, and
environmental factors (especially at the time of birth).
Infant mortality strongly depends on health-system and
hygiene standards but focuses on a very specific aspect of
health. In addition, life expectancy and mortality rates are
probably affected by country-specific rates of accidents,
homicides, and suicides. It is difficult to define health care
outcomes in the same way for all countries using a single
factor, because different countries have different policy
priorities and aims (see [17]). Research shows that there are
strong differences in the extent to which the health system
influences performance measures, ranging from large
effects on measures such as waiting time to very small
effects on mortality, which is strongly influenced by factors
that are not within the purview of the health care system
(see [18]). High infant mortality rates (e.g., in the USA)
may be due to factors such as poverty rather than low
health care system efficiency (see [1]). To account for
mortality rates that are less strongly affected by these
factors, we include 30-day mortality after ischemic stroke
and acute myocardial infarction in our analyses.
We categorize the output indicators into two groups:
specific outputs and unspecific outputs. While recognizing
that this distinction is somewhat fuzzy, we regard the
specific outputs as more closely related to the effects of the
health system than the unspecific outputs. For instance,
infant mortality depends crucially on the hygiene standards
applied and the medical care provided during birth. This is
not true of general life expectancy, which is a weighted
average of the number of deaths in a given year across all
ages. Therefore, the living conditions and health provision
across a period of about 100 years determine the actual
measure of life expectancy. This means that life expec-
tancy can, at best, be only partially attributed to the present
state of the health system. We use the following variables
for our analyses:
1. Specific outputs
– infmort: infant mortality, deaths per 1000 live
births
– ischemicstroke30: 30-day mortality after admis-
sion to hospital for ischemic stroke per 100 patients
(based on admission data).
– amim30: 30-day mortality after admission to
hospital for acute myocardial infarction (AMI)
per 100 patients (based on admission data).
2. Unspecific outputs
– lifeexp: life expectancy at birth.
4.4.3 Economic Conditions and Lifestyle
It is not easy to correlate health status with the activities
performed by health care systems. There are other non-
health variables that are outside the range of influence of
the health care system but can affect health, such as
environmental conditions (e.g., temperature, pollution),
socioeconomic factors (e.g., education, income, employ-
ment), and health-related behaviors and lifestyle (e.g.,
alcohol and tobacco consumption, hygiene) of the popu-
lation. But these factors are not routinely measured and
they are highly correlated with each other. For instance,
many behavioral factors are correlated with educational
attainment (see [3]) and measures of income. Therefore, we
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face the problem of using a combination of macro (e.g.,
education, employment) and intermediate (e.g., smoking,
alcohol) factors in the DEA model which could lead to
biased results (see [11]). We categorize the analyzed
variables into economic conditions and lifestyle inputs:
1. Economic conditions
– gdp_ppp: GDP per capita in US dollars, based on
PPP
– gini: Gini coefficient of income distribution (dis-
posable income after taxes and transfers).
2. Lifestyle input
– alcohol: alcohol consumption in liters per capita,
population aged 15?
– tobacco: % of population aged 15? who are daily
smokers
– obesity: % of population aged 15?.
4.5 Methodology
Unfortunately, a large number of values are missing from
the OECD health data. An all-encompassing analysis
would only be possible for an extremely small number of
countries. Thus, we instead focus on several aspects of
health systems and conduct five partial analyses, as dis-
played in Fig. 3. Note that the analyses differ in the number
of countries they consider. Moreover, we assume that
separate analyses of specific aspects of health care provi-
sion are useful for providing detailed information on how a
country’s health care system works.
The first analysis (analysis I) focuses on the efficiency of
surgery provision. Outputs are cataract and bypass surg-
eries and kidney transplantations (per 100,000 population).
We use the numbers of physicians, nurses, and beds (per
1000 population) as medical inputs.
In the second analysis (analysis II), we focus on the
efficiency of mortality prevention, defined by infant mor-
tality, mortality 30 days after stroke, and mortality 30 days
after infarct. Medical inputs are again the numbers of
physicians, nurses, and beds (per 1000 population).
The third analysis (analysis III) concentrates on the
effects of lifestyle on life expectancy from birth. Alcohol
consumption, smoking, and obesity are used as lifestyle
inputs.
The focus of the fourth analysis (analysis IV) is on the
effects of income and health expenditure on life expectancy
from birth. Income is measured as the gross domestic
product per capita (GDP/Pop.). Expenditure is measured as
the health expenditure per capita (HExp/Pop.).
In the fifth analysis (analysis V), we concentrate on the
effects of relative expenditure, measured as the ratio of
health expenditure to GDP (HExp/GDP), and inequality,
measured as the Gini coefficient, on life expectancy from
birth.
We use an input-oriented data envelopment analysis
(DEA), as described in Sect. 2, with constant returns to
scale. The idea of DEA is that price vectors are selected for
each unit that maximize efficiency given a set of con-
straints, i.e., DEA provides the ‘‘optimal’’ price vectors u
and v for all n health systems. u and v vary strongly
between units, and in many cases several input and output
prices are zero. Even when DEA was first applied by
Charnes et al. [19], some DMUs obtained zero weights, and
all but one of the several inputs of some efficient units had
zero weights.
Charnes et al. [20] question restrictions on the firm’s
individual optimal weights. Allen et al. [21] provide a
discussion of value judgements of weights obtained by
DEA and a priori weight restrictions by the researcher, and
regard the existence of zero weights as a conceptual
problem with DEA. Due to the nature of value judgements,
they understandably conclude that ‘‘There is no all purpose
method for translating value judgements into restrictions
on DEA weights’’ (p. 30). To circumvent the introduction
of value judgements, we decided to use means of DEA
weights as an alternative to original DEA scores.
In detail, we use DEA weights averaged over all coun-























Fig. 3 Five partial analyses.
GDP gross domestic product,
Pop. population, HExp health
expenditure
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alternative relative productivity measure: the ratio of a
country’s productivity to the productivity of the most
productive country. We obtain average ‘‘optimal’’ input
and output price vectors u and v based on the n individual
input and output price vectors. We calculate aggregates of












The impact of varying the weights of the health system
outputs is discussed in, for example, Lauer et al. [22]. They
criticize the use of fixed output weights for all of the
countries considered in the WHO health-system perfor-
mance rankings. Fixed weights do not account for the
development status or cultural traditions of a particular
country, or for the different political objectives of different
countries. This issue becomes more important as the range
of income levels across the countries considered increases.
Therefore, this issue is of less concern when investigating
the (relatively similar) OECD countries than when con-
sidering the broader set of countries included in the WHO
database. Hauck and Street [23] try to avoid the drawbacks
of aggregating multiple objectives into one single index by
applying a multivariate multilevel model.
To carry out the DEA, we have to transform some of our
variables. The output (input) should be  0, and the output
(input) should be ‘‘good’’ instead of ‘‘bad.’’ For instance,
Cheng and Zervopoulos [24] use a generalized directional
distance function to handle desirable and undesirable out-
puts. Seiford and Zhu [25] propose a linear monotonically
decreasing transformation for undesirable outputs and
output-decreasing inputs. In our analysis, mortality rates
and lifestyle inputs such as the amount of alcohol must be
transformed. x denotes the original variable (e.g., mortality
rate), ~x is the scaled variable (with a mean of 0 and a
standard deviation of 1), and x the transformed variable:
~x ¼ xmeanðxÞ
sdðxÞ
x ¼ ~xminð~xÞ þ 1:
Note that x has a minimum value of 1 for the health
system with the smallest output (i.e., the highest mortality
rate) and a standard deviation of 1. The Gini coefficient is
transformed into 1 Gini, as 1 Gini is regarded as a
sensible equality measure.
5 Empirical Results
In the following, we present results for the five analyses
separately. The tables provide information on the inputs
and outputs used, the relative inputs and outputs (measured
as the ratio of the country’s weighted (by the mean input/
output prices) sum of inputs/outputs and the maximum
inputs/outputs of any country), the DEA efficiency scores,
as well as the relative productivity of each country, based
on the mean of the country-specific optimal prices across
all countries. Relative productivity is by definition nor-
malized to the interval [0, 1] and is therefore easily inter-
pretable.1 Note that the average implicit weights in the last
row of each of the following tables refer to the scaled
variables, and—for ease of interpretation—we also provide
the original input and output values in the tables.
We observe that the optimal prices for inputs and out-
puts vary considerably across countries, with several prices
being zero. This fact is discussed by Lauer et al. [22], who
criticize the fact that a country can greatly increase its
efficiency score by assigning zero weights to inputs and/or
outputs it is not performing well in.
5.1 Analysis I: Surgeries
Table 2 shows the results for analysis I, comparing the
efficiency of surgery provision.2 According to the DEA
efficiency scores for each of the 19 considered countries,
we find 7 countries to be efficient (score of 1): Belgium,
Canada, Estonia, Hungary, Korea, Spain, and Sweden.
Very inefficiently performing countries are Lithuania
(0.649), New Zealand (0.652), and Germany (0.658); for
instance, Lithuania could potentially reduce its inputs by
35.1% but still achieve its current output.
The measure of relative productivity reveals Hungary to
be the most productive country (1.000), followed by
Estonia (0.979), and Korea (0.932). We observe low pro-
ductivities for New Zealand (0.227) and Denmark (0.370).
Comparing the DEA efficiency score with the relative
productivity reveals, for the majority of countries, a strong
divergence between both measures, with the latter being
considerably lower than the former. For example, for
Sweden and the UK, the relative productivity is about half
the DEA efficiency score (with country-specific input pri-
ces strongly diverging from the mean prices). Therefore,
variations in input and output prices appear to have a strong
impact on the productivity and efficiency values of the
countries considered (see also [22]). The correlation
between DEA score and relative productivity based on
average prices is 0.61. These results indicate that in DEA,
countries emphasize their strengths and ignore aspects of
health provision at which they are poor performers.
1 Tables with implicit DEA prices for the used inputs and outputs are
available upon request.
2 We used the R programming environment throughout. The
efficiency analysis was carried out using the simplex function
provided in the boot package.
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5.2 Analysis II: Mortality
Table 3 presents the results for analysis II, focusing on the
efficiency of mortality prevention. We find 6 out of the 22
considered countries to be efficient: Canada, Finland,
Israel, Korea, Slovenia, and Sweden. Canada, Korea, and
Sweden were also identified as efficient in the first analysis.
Very inefficient are Austria (0.624), again Germany
(0.645), and Mexico (0.403), which is an obvious outlier. A
closer look at the used (relative) inputs and outputs reveals
low input and a very low output in Mexico. We find that
efficient countries achieve their efficiency in rather dif-
ferent ways; for example, by investing a medium quantity
of input but producing comparably high output (e.g.,
Canada) or by investing a high quantity of input and pro-
ducing very high output (e.g., Sweden). This fact is also
mentioned by Afonso and Aubyn [8].
The measures of relative productivity reveal Israel to be
the most productive country (1.000), followed by Spain
(0.788), Korea (0.771), and Canada (0.762). As also seen in
analysis I, we observe some divergence between the DEA
efficiency score and the relative productivity for most
countries, with the latter again being considerably lower
than the former. Despite the marked differences between
the values of these measures, the correlation between DEA
score and relative productivity based on average prices is
actually rather strong (0.77).
5.3 Analysis III: Lifestyles
Results for analysis III, focusing on the effects of different
lifestyles on life expectancy, are summarized in Table 4.
Here, we observe 16 countries, 5 of which are identified as
efficient: Estonia, Luxembourg, Mexico, UK, and the
United States. Very low efficiency scores are recorded for
Japan (0.580), Sweden (0.626), and Norway (0.643).
Interestingly, Sweden was found to be efficient in the first
two analyses and Mexico to be substantially inefficient in
analysis II. A closer look at inputs and outputs indicates
that Mexico is characterized by the highest percentage of
obesity in the population, but life expectancy is sufficient
for it to be characterized as an efficient country.
Based on the relative productivity, we again find Swe-
den (0.543), Japan (0.565), and Norway (0.591) to perform
rather inefficiently. The highest productivity is reported for
Estonia (1.000), followed by the UK (0.911). Again, we
observe some differences between DEA efficiency scores
and relative productivity values; the correlation between
DEA score and relative productivity is 0.78. For Mexico,
we observe a large difference between scores based on
Table 2 Analysis I: medical inputs and surgeries
Beds Phys. Nurses Catar. Bypass Kidney Rel.inp. Rel.outp. Eff. Rel.prod.
Austria 5.460 4.900 7.830 11.250 0.435 0.049 0.488 0.989 0.865 0.819
Belgium 3.990 2.930 9.510 10.921 0.644 0.049 0.586 1.000 1.000 0.690
Canada 1.710 2.480 9.350 10.531 0.561 0.038 0.574 0.953 1.000 0.670
Czech Republic 4.560 3.670 8.060 10.399 0.501 0.041 0.499 0.932 0.834 0.754
Denmark 2.530 3.620 16.300 9.799 0.679 0.047 1.000 0.916 0.846 0.370
Estonia 3.550 3.280 6.170 10.734 0.327 0.045 0.383 0.928 1.000 0.979
Finland 2.920 3.010 14.120 9.538 0.472 0.036 0.866 0.857 0.762 0.400
Germany 5.380 3.960 12.610 9.643 0.684 0.032 0.777 0.903 0.658 0.470
Hungary 3.980 3.090 6.320 9.969 0.910 0.030 0.392 0.970 1.000 1.000
Israel 1.890 3.250 4.820 5.416 0.372 0.023 0.300 0.505 0.887 0.680
Korea 6.120 2.080 4.840 8.417 0.066 0.036 0.301 0.693 1.000 0.932
Lithuania 5.380 4.220 7.590 5.314 0.621 0.028 0.472 0.542 0.649 0.464
Luxembourg 3.960 2.780 11.920 9.618 0.465 0.000 0.732 0.859 0.815 0.474
New Zealand 2.610 2.700 9.970 3.270 0.437 0.024 0.613 0.344 0.652 0.227
Poland 4.320 2.230 5.560 3.480 0.546 0.026 0.344 0.381 0.935 0.447
Slovenia 3.620 2.540 8.160 8.914 0.406 0.011 0.503 0.793 0.860 0.637
Spain 2.300 3.820 5.240 6.116 0.177 0.055 0.327 0.529 1.000 0.654
Sweden 1.950 4.010 11.150 9.391 0.346 0.045 0.687 0.823 1.000 0.484
UK 2.310 2.750 8.210 6.198 0.287 0.040 0.506 0.554 0.942 0.443
Mean 3.607 3.227 8.828 8.364 0.470 0.034 0.545 0.762 0.879 0.610
Impl. pr. 0.045 0.270 8.589 0.069 0.154 0.060
Phys. physicians, Catar. cataract, Eff. efficiency, Prod. productivity
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country-specific prices and on mean prices. While Mexico
is regarded as efficient according to its DEA score, its
efficiency in terms of relative productivity is below
average.
5.4 Analysis IV: Per Capita Income and Health
Care Spending
In the fourth analysis (Table 5), investigating the efficiency
of income and health expenditure per capita, we observe
only Mexico and Turkey to be efficient among the 30
countries considered. Luxembourg (0.222), Norway
(0.278), Switzerland (0.335), and the USA (0.346) are
characterized as very inefficient countries. All of these
countries use high input quantities (primarily GDP for
Luxembourg, health expenditure for USA), which is not
sufficiently reflected in their life expectancies. Interest-
ingly, the efficient countries Mexico and Turkey provide
very low input and produce low output. This indicates that
increased absolute health spending and income per capita
have only moderate effects on life expectancy.
Based on the relative productivity, Mexico is the most
productive country (1.000), followed by Turkey (0.943)
and Chile (0.829). Countries with a low relative produc-
tivity are again Luxembourg (0.201) and Norway (0.276).
The correlation between both efficiency measures is close
to 1.
5.5 Analysis V: Relative Health Care Spending
and Inequality
Analysis V focuses on the efficiency of relative health
expenditure and inequality. Results for the 27 countries are
presented in Table 6. Resembling the results of analysis IV,
only two countries have an efficiency score of 1: Mexico
and Turkey. The next most efficient countries are Israel
(0.950) and the USA (0.943). In general, efficiency scores
are close to 1; the lowest score of 0.765 is reported for the
Slovak Republic. Mexico as well as Turkey report high
Gini coefficients and low life expectancies. As income
inequality has a negative but rather indirect effect on life
expectancy, we find that the ultimately negative effect of
Table 3 Analysis II: medical inputs and mortality
Beds Phys. Nurses Infmort Stroke30 Ami30 Rel. inp Rel.outp. Eff. Rel.prod.
Australia 3.360 3.310 10.220 5.227 3.830 5.984 0.743 0.859 0.846 0.623
Austria 5.460 4.900 7.830 5.269 4.643 4.749 0.922 0.899 0.624 0.525
Belgium 3.990 2.930 9.510 5.015 3.858 5.333 0.741 0.829 0.814 0.603
Canada 1.710 2.480 9.350 4.593 3.550 5.468 0.551 0.778 1.000 0.762
Czech Republic 4.560 3.670 8.060 5.522 3.802 5.445 0.787 0.858 0.756 0.588
Denmark 2.530 3.620 16.300 5.184 3.915 5.557 0.883 0.851 0.771 0.520
Estonia 3.550 3.280 6.170 5.100 2.794 4.457 0.637 0.709 0.841 0.600
Finland 2.920 3.010 14.120 5.607 4.923 5.378 0.807 0.965 1.000 0.645
Germany 5.380 3.960 12.610 5.227 4.587 4.974 0.994 0.898 0.645 0.487
Iceland 2.290 3.570 15.160 6.156 4.223 5.423 0.830 0.936 0.991 0.607
Israel 1.890 3.250 4.820 5.100 4.447 5.535 0.482 0.895 1.000 1.000
Japan 7.940 2.290 10.540 5.691 5.624 4.233 1.000 1.000 0.958 0.539
Korea 6.120 2.080 4.840 5.396 5.512 5.019 0.696 0.995 1.000 0.771
Luxembourg 3.960 2.780 11.920 5.565 3.915 5.400 0.799 0.870 0.914 0.587
Mexico 1.530 2.120 2.550 1.000 1.000 1.000 0.318 0.185 0.403 0.313
New Zealand 2.610 2.700 9.970 4.423 4.083 5.445 0.645 0.816 0.950 0.682
Norway 2.340 4.230 16.530 5.565 4.895 5.310 0.917 0.958 0.879 0.563
Slovenia 3.620 2.540 8.160 5.945 2.766 5.535 0.651 0.791 1.000 0.655
Spain 2.300 3.820 5.240 5.311 3.606 5.153 0.560 0.818 0.955 0.788
Sweden 1.950 4.010 11.150 5.522 4.783 5.961 0.719 0.965 1.000 0.723
Switzerland 2.990 3.920 16.970 5.100 4.531 5.243 0.954 0.893 0.774 0.505
UK 2.310 2.750 8.210 4.888 3.662 5.198 0.576 0.799 0.952 0.747
Mean 3.423 3.237 10.010 5.109 4.043 5.082 0.737 0.844 0.867 0.629
Impl. pr. 0.076 0.073 0.032 0.101 0.152 0.050
Phys. physicians, Infmort infant mortality, Stroke30 30-day mortality after admission to hospital for ischemic stroke per 100 patients, Ami30
30-day mortality after admission to hospital for acute myocardial infarction per 100 patient, Eff. efficiency, Prod. productivity
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high inequality (e.g., in Mexico) is not reflected in an
accordingly low life expectancy.
Relative productivity is lowest for the Slovak Republic
(0.742). Mexico has the highest relative productivity
(1.000), followed by Israel (0.949) and the USA (0.942).
We observe only small differences between DEA effi-
ciency scores and relative productivity, and a very strong
correlation between both efficiency measures (0.92).
5.6 Synopsis
Table 7 in the Appendix provides an overview of the DEA
scores obtained in all five analyses of 34 countries. The
mean is calculated on the basis of 1–5 DEA efficiency
scores, and the ranking is based on the mean. We observe
Iceland to be the most efficient country, followed by Tur-
key and Estonia. The lowest mean efficiency scores are
reported for Ireland and Germany.
Efficiency scores vary strongly across the five analyses,
with some countries performing efficiently in one or more
analyses and very inefficiently in others (e.g., Mexico,
Canada, and Sweden). Therefore, countries can indeed be
efficient at producing specific health care outputs and
inefficient at producing others. For example, Mexico is
identified as efficient at producing life expectancy, due to
its very low input, but inefficient at preventing mortality.
This result emphasizes the value of disaggregated analysis,
as a combined analysis would probably mask important
specific inefficiencies.
We observe for some countries that financial inputs
could be strongly reduced without degrading the current
output. The potential increase in output with improvements
in lifestyle inputs is much lower. For example, for Canada,
we find that there is great potential to reduce financial
inputs (GDP per capita, health expenditure per capita)
without negatively impacting life expectancy, but a lower
potential to reduce lifestyle inputs. Also, for Austria, we
observe great potential to reduce medical inputs for mor-
tality, but not to reduce inputs for surgeries.
6 Conclusions
In this study, we investigated the efficiencies of the health
care systems of various OECD countries based on OECD
health data. We focused on specific aspects of the health
care systems and conducted five separate partial analyses
investigating the effiects of medical inputs on surgery
provision, medical inputs on mortality prevention, lifestyle
on life expectancy from birth, income and health expen-
diture per capita on life expectancy from birth, and health
expenditure relative to GDP and income equality on life
expectancy from birth.
We applied an input-oriented data envelopment analysis
(DEA) assuming constant returns to scale. DEA provides
optimal input and output weights for each country, maxi-
mizing each country’s efficiency, given a set of constraints.
The obtained optimal weights of the linear problem in
Table 4 Analysis III: lifestyle
inputs and life expectancy
Alcohol Tobacco Obese Lifexp Rel. inp Rel.outp. Eff. Rel.prod.
Canada 8.100 16.100 50.900 81.450 0.852 0.980 0.710 0.635
Estonia 12.200 27.250 48.900 76.450 0.508 0.919 1.000 1.000
Finland 9.300 17.450 49.400 80.700 0.820 0.971 0.748 0.654
France 11.700 24.450 44.400 82.050 0.645 0.987 0.922 0.845
Japan 7.200 21.550 23.700 83.150 0.977 1.000 0.580 0.565
Luxembourg 11.300 16.800 59.200 81.450 0.726 0.980 1.000 0.745
Mexico 5.700 12.300 71.300 74.350 0.764 0.894 1.000 0.647
Netherlands 9.100 18.450 47.900 81.150 0.806 0.976 0.738 0.669
New Zealand 9.200 16.500 63.800 81.150 0.697 0.976 0.967 0.774
Norway 6.200 16.000 46.000 81.500 0.916 0.980 0.643 0.591
Slovenia 11.000 20.500 56.900 80.200 0.638 0.965 0.988 0.836
Sweden 7.300 12.750 47.100 81.750 1.000 0.983 0.626 0.543
Switzerland 9.900 20.450 41.000 82.750 0.814 0.995 0.732 0.676
Turkey 1.600 24.000 52.000 74.600 0.627 0.897 0.887 0.791
UK 9.700 20.500 61.900 80.950 0.591 0.974 1.000 0.911
USA 8.800 14.200 68.600 78.800 0.719 0.948 1.000 0.729
Mean 8.644 18.703 52.062 80.153 0.756 0.964 0.846 0.726
Impl. pr. 0.011 0.109 0.102 0.224
Lifexp life expectancy at birth, Eff. efficiency, Prod.: productivity
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multiplier form varied strongly among countries, with
several input and output prices being 0, pointing to slacks.
Since DEA allows countries to emphasize the impor-
tance of specific inputs and outputs, allowing the efficiency
to be exaggerated, we also used average prices for aggre-
gation and constructed an alternative measure of relative
productivity. Economically, zero weights are dubious, as
the DEA scores then rest on dubious assumptions; for
instance, that beds and physicians in Denmark and in the
UK are costless (analysis I). The measure of relative pro-
ductivity is therefore more informative if all countries face
rather similar input prices. The correlation between DEA
score and relative efficiency differed across the five anal-
yses but was generally rather strong.
We observed efficiency scores to vary substantially
across the five analyses, with some countries being efficient
in one or more analyses and very inefficient in others.
Therefore, countries were found to be efficient at producing
specific health care outputs but very inefficient at produc-
ing others. Furthermore, we found that efficient countries
could achieve their high efficiencies in several ways. The
rankings of the 34 considered countries, based on the mean
of 1–5 efficiency scores, revealed that Iceland was the most
efficient country, followed by Turkey and Estonia. The
lowest ranking were obtained for Ireland and Germany.
Inefficient countries have to decide whether to focus on
input reduction or output improvement to become more
efficient. The benchmark country chosen as a reference
Table 5 Analysis IV: absolute
expenditure/income and life
expectancy
Hspend Gdp Lifexp Rel. inp Rel.outp. Eff. Rel.prod.
Austria 4.528 44.873 81.000 0.496 0.974 0.408 0.404
Belgium 4.225 41.397 80.450 0.457 0.968 0.439 0.435
Canada 4.304 42.128 81.450 0.465 0.980 0.437 0.432
Chile 1.476 21.412 78.700 0.234 0.946 0.831 0.829
Czech Republic 2.021 28.643 78.150 0.314 0.940 0.617 0.615
Denmark 4.512 43.560 80.100 0.481 0.963 0.416 0.411
Estonia 1.341 24.735 76.450 0.270 0.919 0.725 0.700
Finland 3.403 40.209 80.700 0.442 0.971 0.454 0.451
France 4.045 37.456 82.050 0.414 0.987 0.495 0.489
Germany 4.693 43.523 80.950 0.482 0.974 0.420 0.415
Hungary 1.697 22.494 75.150 0.247 0.904 0.755 0.752
Ireland 3.663 45.242 80.950 0.497 0.974 0.404 0.402
Israel 2.127 31.629 81.750 0.346 0.983 0.584 0.583
Italy 3.137 35.525 82.300 0.391 0.990 0.524 0.520
Japan 3.592 35.611 83.150 0.393 1.000 0.528 0.522
Korea 2.142 32.022 81.250 0.350 0.977 0.574 0.573
Luxembourg 4.371 91.850 81.450 1.000 0.980 0.222 0.201
Mexico 1.026 16.808 74.350 0.184 0.894 1.000 1.000
Netherlands 5.081 46.054 81.150 0.510 0.976 0.398 0.393
Norway 5.823 66.363 81.500 0.730 0.980 0.278 0.276
Poland 1.448 23.152 76.850 0.253 0.924 0.750 0.750
Portugal 2.523 27.000 80.450 0.298 0.968 0.674 0.668
Slovak Republic 1.977 25.718 76.200 0.282 0.916 0.670 0.667
Slovenia 2.483 28.450 80.200 0.313 0.965 0.637 0.633
Spain 2.957 32.770 82.500 0.361 0.992 0.569 0.565
Sweden 4.743 43.869 81.750 0.485 0.983 0.421 0.416
Switzerland 6.140 55.916 82.750 0.619 0.995 0.335 0.330
Turkey 0.890 17.935 74.600 0.195 0.897 1.000 0.943
UK 3.175 37.386 80.950 0.411 0.974 0.489 0.486
USA 8.454 51.496 78.800 0.578 0.948 0.346 0.337
Mean 3.400 37.841 79.935 0.417 0.961 0.547 0.540
Impl. pr. 0.007 0.025 0.029
Hspend total health expenditure per capita in US dollars based on purchasing power parity, Gdp gross
domestic product per capita in US dollars based on purchasing power parity, Lifexp life expectancy at birth,
Eff. efficiency, Prod. productivity
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when making this decision will depend on the preferences
of the country that is making this choice. Our individual
analyses allowed us to identify, for each country, which of
the outputs/inputs had the greatest potential to be
increased/reduced to obtain efficiency gains.
In analysis I (medical inputs and surgeries), we found that
Germany was inefficient at producing surgeries. A closer
look at inputs and outputs for Germany revealed that that its
utilization of about 78% of themaximum input yields 90% of
the maximum output (as produced by the efficient country of
Belgium). As Germany is a rather rich country, it would
probably be more logical to increase output to the highest
observed level rather than reducing inputs. A comparison
with Belgium, the relevant benchmark country, reveals that
Germany produces far fewer kidney transplantations and
cataract surgeries. Therefore, more efficient organization of
transplantations would increase Germany’s health care sys-
tem efficiency in this specific aspect. According to this
reasoning, Spain—which also belongs to the reference set—
would probably be less suitable for use as a benchmark due to
its comparatively low output.
On the other hand, Denmark is the country with the highest
sum of weighted inputs in most analyses, so it could focus on
reducing inputs rather than on further increasing its already
high output. Looking at the inputs reveals that there is great
potential to reduce the number of practicing nurses, which is
very high compared to all other countries. But, of course, the
route to improving Danish health care efficiency depends on
the preferences of theDanish population or its representatives.
Again using Germany as example, analysis II (medical
inputs and mortality) revealed that there is high potential to
increase outputs in order to become efficient. Using
Japan—the country with the highest sum of outputs—as a
benchmark, Germany has considerable potential to reduce
its 30-day mortality after admission to hospital for
ischemic stroke. But, as Germany is also the country with
Table 6 Analysis V: healthcare
expenditure/GDP, Gini, and life
expectancy
Hgdp Gini Lifexp Rel. inp Rel.outp. Eff. Rel.prod.
Austria 0.101 0.276 81.000 0.964 0.979 0.817 0.817
Belgium 0.102 0.268 80.450 0.975 0.972 0.803 0.803
Czech Republic 0.071 0.256 78.150 0.990 0.944 0.810 0.767
Denmark 0.104 0.249 80.100 1.000 0.968 0.779 0.779
Estonia 0.057 0.338 76.450 0.881 0.924 0.917 0.844
Finland 0.085 0.260 80.700 0.985 0.975 0.796 0.796
France 0.108 0.306 82.050 0.924 0.992 0.863 0.863
Germany 0.108 0.289 80.950 0.947 0.978 0.832 0.831
Hungary 0.075 0.289 75.150 0.947 0.908 0.787 0.772
Ireland 0.081 0.304 80.950 0.927 0.978 0.849 0.849
Israel 0.070 0.371 81.750 0.837 0.988 0.950 0.949
Italy 0.088 0.327 82.300 0.896 0.995 0.893 0.893
Korea 0.067 0.307 81.250 0.923 0.982 0.899 0.856
Luxembourg 0.066 0.302 81.450 0.929 0.984 0.900 0.852
Mexico 0.061 0.457 74.350 0.723 0.898 1.000 1.000
Netherlands 0.110 0.281 81.150 0.957 0.981 0.824 0.824
Norway 0.088 0.253 81.500 0.995 0.985 0.797 0.797
Poland 0.063 0.298 76.850 0.934 0.929 0.860 0.800
Portugal 0.093 0.338 80.450 0.882 0.972 0.888 0.887
Slovak Republic 0.077 0.250 76.200 0.998 0.921 0.765 0.742
Slovenia 0.087 0.250 80.200 0.999 0.969 0.781 0.781
Spain 0.090 0.335 82.500 0.885 0.997 0.906 0.906
Sweden 0.108 0.274 81.750 0.967 0.988 0.822 0.822
Switzerland 0.110 0.285 82.750 0.952 1.000 0.845 0.845
Turkey 0.050 0.402 74.600 0.796 0.902 1.000 0.911
UK 0.085 0.351 80.950 0.864 0.978 0.911 0.911
USA 0.164 0.390 78.800 0.813 0.952 0.943 0.942
Mean 0.088 0.308 79.806 0.922 0.964 0.861 0.846
Impl. pr. 0.011 1.548 1.305
Hgdp health expenditure as share of gross domestic product, Gini Gini coefficient, Lifexp life expectancy at
birth, Eff. efficiency, Prod. productivity
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the second highest use of inputs, there is also great
potential for input reduction (particularly beds and nurses,
which are well above average). Austria, which has very
similar efficiency measures and similar relative inputs and
outputs to Germany, has the greatest potential to reduce
beds and physicians to increase efficiency.
In analysis III (lifestyle and mortality), we observed that
Japan was the most inefficient country despite presenting
the highest output. Japan uses a very high amount of
weighted inputs, which, in the case of ‘‘bad’’ inputs, means
that there is low alcohol and tobacco consumption as well
as low obesity in Japan. As increasing these inputs is not
realistic policy advice, Japan would have to increase its
average life expectancy—which is already the highest in
the world—to become more efficient. But the fact that
many countries with rather unhealthy lifestyles have
above-average live expectancies (e.g., France and the UK)
indicates that lifestyle is a relatively minor determinant
(among many others) of life expectancy.
The results of analysis IV (absolute expenditure/income
and life expectancy) hinted strongly that absolute income
and health spending per capita have no proportional effect on
life expectancy. Some high-income and high-spending
countries have extremely low efficiency scores (Luxem-
bourg,Norway, Switzerland, and theUSA). For instance, life
expectancy in Switzerland is 99.5% of the highest observed
value (for Japan), but the efficiency score for Switzerland is
only 0.335. As reducing GDP is not a meaningful option for
policymakers to increase the efficiency of the health care
system, there is probably only some potential to decrease
health expenditure. Similar arguments hold for analysis V
(relative spending/inequality and life expectancy), as we
again observed only very moderate effects of relative health
care spending and equality on life expectancy.
Summing up, we found that analyses I and II hinted
much more strongly at possible policy recommendations
than analyses III–V did. We also agree with Medeiros and
Schwierz [14], who conclude that for countries with
already high life expectancies, focusing on inputs seems to
be a more relevant path for policymakers.
We conclude that performing separate analyses of
specific aspects of health care provision is a useful
approach for shedding light on how a country’s health care
system works in detail. It provides important information
that can be used to pinpoint where policy interventions
should be focused to improve specific parts of a country’s
health care system.
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Table 7 Overview: DEA scores
Country e1 e2 e3 e4 e5 Mean Rank
Australia 0.846 0.846 13.0
Austria 0.865 0.624 0.408 0.817 0.678 28.0
Belgium 1.000 0.814 0.439 0.803 0.764 19.0
Canada 1.000 1.000 0.710 0.437 0.787 15.0
Chile 0.831 0.831 14.0
Czech Republic 0.834 0.756 0.617 0.810 0.754 22.0
Denmark 0.846 0.771 0.416 0.779 0.703 26.0
Estonia 1.000 0.841 1.000 0.725 0.917 0.897 3.0
Finland 0.762 1.000 0.748 0.454 0.796 0.752 23.0
France 0.922 0.495 0.863 0.760 21.0
Germany 0.658 0.645 0.420 0.832 0.639 33.0
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Table 7 continued
Country e1 e2 e3 e4 e5 Mean Rank
Hungary 1.000 0.755 0.787 0.847 12.0
Iceland 0.991 0.991 1.0
Ireland 0.404 0.849 0.626 34.0
Israel 0.887 1.000 0.584 0.950 0.855 8.0
Italy 0.524 0.893 0.708 25.0
Japan 0.958 0.580 0.528 0.689 27.0
Korea 1.000 1.000 0.574 0.899 0.868 4.0
Lithuania 0.649 0.649 31.5
Luxembourg 0.815 0.914 1.000 0.222 0.900 0.770 18.0
Mexico 0.403 1.000 1.000 1.000 0.851 10.0
Netherlands 0.738 0.398 0.824 0.653 30.0
New Zealand 0.652 0.950 0.967 0.856 7.0
Norway 0.879 0.643 0.278 0.797 0.649 31.5
Poland 0.935 0.750 0.860 0.848 11.0
Portugal 0.674 0.888 0.781 16.0
Slovak Republic 0.670 0.765 0.718 24.0
Slovenia 0.860 1.000 0.988 0.637 0.781 0.853 9.0
Spain 1.000 0.955 0.569 0.906 0.857 6.0
Sweden 1.000 1.000 0.626 0.421 0.822 0.774 17.0
Switzerland 0.774 0.732 0.335 0.845 0.672 29.0
Turkey 0.887 1.000 1.000 0.962 2.0
UK 0.942 0.952 1.000 0.489 0.911 0.859 5.0
USA 1.000 0.346 0.943 0.763 20.0
Table 8 Literature overview: OECD data
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